+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Electronic Clinical Outcome Assessment Market By Delivery Mode, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 84 Pages
  • February 2021
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5305578
The Latin America, Middle East and Africa Electronic Clinical Outcome Assessment Solution Market (ECOA) is expected to witness market growth of 20.2% CAGR during the forecast period (2020-2026).

A Patient’s mental state, the prognosis of a disease, illness conditions, and the role of a patient in that situation can be evaluated with the help of Electronic clinical outcome assessment (eCOAs). The process of medical assessment can help in deciding if a drug is prescribed for the treatment or not. Some parts of electronic clinical outcome assessment are Clinician Reported Outcome Assessment (CLINRO), Observer Reported Outcome Assessment (OBSRO), Performance Outcome Assessment (PERFO), and Patient Reported Outcome Assessment (PRO).

There are various healthcare facilities such as health centers, hospitals, and clinical research organizations (CROs) groups that cover health issues. The increasing number of initiatives regarding the deployment of eClinical solutions taken by several private-public bodies & the rising adoption of eCOA among clinical research professionals are some of the primary factors that is expected to fuel the growth of the global eCOA market.

The growth of the eCOA market is anticipated to be propelled by the increasing awareness of the electronic clinical outcome assessment (eCOA) & the effectiveness of these solutions. Leading players can obtain a competitive edge with the help of several research studies that aim to create advanced & new electronic clinical outcome assessment (eCOA); thereby creating various growth avenues for the electronic clinical outcome assessment (eCOA) market. On the other hand, the major restraints for the market growth are the absence of an appropriate healthcare IT framework & difficult regulatory approvals for these solutions in emerging countries.

Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The Web-hosted eCOA market dominated the South Africa Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode in 2019, thereby, achieving a market value of $16.6 Million by 2026. The Cloud-based eCOA market is showcasing a CAGR of 21.6% during (2020 - 2026).

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).

Scope of the Study

Market Segments covered in the Report:

By Delivery Mode
  • Web-hosted eCOA
  • Cloud-based eCOA
  • Licensed enterprises eCOA

By End Use
  • Contract Research Organizations (CROs)
  • Hospitals
  • Academic Institutes
  • Pharma & Biotech Companies
  • Medical Device Manufacturers

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Oracle Corporation
  • Dassault Systemes SE
  • IQVIA Holdings, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • IBM Corporation (Merge Healthcare)
  • Signant Health
  • ERT Clinical
  • eClinical Solutions LLC
  • Castor EDC
  • Anju Software, Inc. (OmniComm Systems)

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Electronic Clinical Outcome Assessment (eCOA) Market, by Delivery Mode
1.4.2 LAMEA Electronic Clinical Outcome Assessment (eCOA) Market, by End Use
1.4.3 LAMEA Electronic Clinical Outcome Assessment (eCOA) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
4.1 LAMEA Web-hosted eCOA Market by Country
4.2 LAMEA Cloud-based eCOA Market by Country
4.3 LAMEA Licensed enterprises eCOA Market by Country
Chapter 5. LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
5.1 LAMEA Contract Research Organizations (CROs) Market by Country
5.2 LAMEA Hospitals Market by Country
5.3 LAMEA Academic Institutes Market by Country
5.4 LAMEA Pharma & Biotech Companies Market by Country
5.5 LAMEA Medical Device Manufacturers Market by Country
Chapter 6. LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Country
6.1 Brazil Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.1.1 Brazil Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.1.2 Brazil Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.2 Argentina Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.2.1 Argentina Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.2.2 Argentina Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.3 UAE Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.3.1 UAE Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.3.2 UAE Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.4 Saudi Arabia Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.4.1 Saudi Arabia Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.4.2 Saudi Arabia Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.5 South Africa Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.5.1 South Africa Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.5.2 South Africa Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.6 Nigeria Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.6.1 Nigeria Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.6.2 Nigeria Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
6.7 Rest of LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market
6.7.1 Rest of LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
6.7.2 Rest of LAMEA Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
Chapter 7. Company Profiles
7.1 Oracle Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Dassault Systemes SE
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.3 IQVIA Holdings, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.4 Parexel International Corporation (Pamplona Capital Management)
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.5 IBM Corporation (Merge Healthcare)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expenses
7.6 Signant Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Acquisition and Mergers:
7.7 ERT Clinical
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.7.2.2 Acquisition and Mergers:
7.8 eClinical Solutions LLC
7.8.1 Company Overview
7.9 Castor EDC
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.10. Anju Software, Inc. (OmniComm Systems)
7.10.1 Company Overview

Companies Mentioned

  • Oracle Corporation
  • Dassault Systemes SE
  • IQVIA Holdings, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • IBM Corporation (Merge Healthcare)
  • Signant Health
  • ERT Clinical
  • eClinical Solutions LLC
  • Castor EDC
  • Anju Software, Inc. (OmniComm Systems)

Methodology

Loading
LOADING...